Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP886090.RADNFPRU9OLCWkzsf8buN8FuyUp5wf2c0vENPgN307FyY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP886090.RADNFPRU9OLCWkzsf8buN8FuyUp5wf2c0vENPgN307FyY130_assertion type Assertion NP886090.RADNFPRU9OLCWkzsf8buN8FuyUp5wf2c0vENPgN307FyY130_head.
- NP886090.RADNFPRU9OLCWkzsf8buN8FuyUp5wf2c0vENPgN307FyY130_assertion description "[Here, to enhance the BMS-214662 apoptotic effect, we further targeted the extracellular signal-regulated kinase (ERK) pathway, downstream of BCR-ABL, by treating CD34+ CML stem/progenitor cells with a highly selective adenosine triphosphate (ATP) non-competitive MEK inhibitor, PD184352.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP886090.RADNFPRU9OLCWkzsf8buN8FuyUp5wf2c0vENPgN307FyY130_provenance.
- NP886090.RADNFPRU9OLCWkzsf8buN8FuyUp5wf2c0vENPgN307FyY130_assertion evidence source_evidence_literature NP886090.RADNFPRU9OLCWkzsf8buN8FuyUp5wf2c0vENPgN307FyY130_provenance.
- NP886090.RADNFPRU9OLCWkzsf8buN8FuyUp5wf2c0vENPgN307FyY130_assertion SIO_000772 21483442 NP886090.RADNFPRU9OLCWkzsf8buN8FuyUp5wf2c0vENPgN307FyY130_provenance.
- NP886090.RADNFPRU9OLCWkzsf8buN8FuyUp5wf2c0vENPgN307FyY130_assertion wasDerivedFrom befree-20140225 NP886090.RADNFPRU9OLCWkzsf8buN8FuyUp5wf2c0vENPgN307FyY130_provenance.
- NP886090.RADNFPRU9OLCWkzsf8buN8FuyUp5wf2c0vENPgN307FyY130_assertion wasGeneratedBy ECO_0000203 NP886090.RADNFPRU9OLCWkzsf8buN8FuyUp5wf2c0vENPgN307FyY130_provenance.